Loading…
BioHarvest Sciences Inc. Common Stock is projected to rise to $4.21 by 2027, a +7% move from its current price of $3.92. BHST is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $3.83 | $3.92 | $4.01 | +0.01% |
| May 30 | $3.80 | $3.92 | $4.05 | +0.02% |
| May 31 | $3.77 | $3.92 | $4.08 | +0.03% |
| Jun 1 | $3.75 | $3.92 | $4.10 | +0.04% |
| Jun 2 | $3.73 | $3.92 | $4.12 | +0.05% |
| Jun 3 | $3.71 | $3.92 | $4.14 | +0.06% |
| Jun 4 | $3.70 | $3.92 | $4.16 | +0.07% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.70 | $3.92 | $4.16 | +0.07% |
| Week 2 | $3.61 | $3.93 | $4.27 | +0.14% |
| Week 3 | $3.55 | $3.93 | $4.35 | +0.21% |
| Week 4 | $3.49 | $3.93 | $4.42 | +0.28% |
| Week 5 | $3.45 | $3.93 | $4.49 | +0.35% |
| Week 6 | $3.41 | $3.94 | $4.55 | +0.42% |
| Week 7 | $3.37 | $3.94 | $4.60 | +0.49% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
BioHarvest Sciences Inc. is a biotechnology company operating in Israel and the United States, with two segments: Products and CDMO Services. It develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients and is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional foods and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions.
The company also provides contract development and manufacturing operation services and offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada.
BHST is a Biotechnology stock in the Consumer Defensive category. It is currently priced at $3.86 per share, with a market capitalization of $87.5M and a rank of 4314.
The near-term outlook shows a gradual path of upside in the forecast, with 2026 avg at $3.86, 2027 avg at $4.11, 2028 avg at $4.25, 2029 avg at $4.95, 2030 avg at $5.59, and continuing higher through 2035 (avg $7.57) and into 2040 ($9.16) and 2050 ($16.26). Max values rise accordingly, culminating at $28.51 in 2050, with multi-year bullish sentiment beginning in 2029.
A major floor 16.3% below — a decisive break under it would weaken the trend.
The nearest floor, 5.9% below — buyers have tended to step in here.
The nearest ceiling, 12.8% above — a clean break opens room to run.
A major ceiling 47.2% above — clearing it would confirm fresh momentum.
Key BHST support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BHST market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.85 | Buy | $3.89 | Buy |
| MA 10 | $3.94 | Sell | $3.92 | Sell |
| MA 20 | $4.01 | Sell | $4.00 | Sell |
| MA 50 | $4.20 | Sell | $4.22 | Sell |
| MA 100 | $4.50 | Sell | $4.72 | Sell |
| MA 200 | $6.41 | Sell | $5.49 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.79 | Neutral |
| Stoch RSI (14) | 81.17 | Sell |
| CCI (20) | -39.94 | Neutral |
| Williams %R (14) | -51.06 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -1.26 | Sell |
| Bollinger %B (20,2) | 0.37 | Neutral |
| Stochastic %K (14) | 48.94 | Neutral |
| TRIX (15) | -0.36 | Sell |
| Awesome (5,34) | -0.30 | Sell |
| Ultimate (7,14,28) | 37.52 | Neutral |
| Momentum (10) | 0.08 | Buy |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 3.85 | Buy |
| ADX (14) | 18.34 | Neutral |
| ATR (14) | 0.08 | Info |
The 30-day technical picture is Bearish. The RSI(14) sits at 40, indicating soft momentum relative to typical overbought/oversold levels. The near-term moving averages show the SMA50 at $4.22 and the SMA200 at $6.45, suggesting a current bias lower than longer-term averages.
Prices are trading near support at $3.69 and face resistance at $4.42, with the 30-day range spanning from $3.31 to $4.51. This configuration underscores a constrained near-term range with limited upside pressure until a breakout beyond resistance or a move back toward the support level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.69 | $3.92 | $4.67 | 0% | Neutral | |
| $3.40 | $4.21 | $5.49 | +7% | Neutral | |
| $3.49 | $4.42 | $5.93 | +13% | Neutral | |
| $3.96 | $5.11 | $7.03 | +30% | Bullish | |
| $4.40 | $5.76 | $8.09 | +47% | Bullish | |
| $4.28 | $5.69 | $8.14 | +45% | Bullish | |
| $4.44 | $5.98 | $8.68 | +52% | Bullish | |
| $4.49 | $6.13 | $9.03 | +56% | Bullish | |
| $4.62 | $6.38 | $9.52 | +63% | Bullish | |
| $5.65 | $7.90 | $11.94 | +101% | Bullish | |
| $6.65 | $9.77 | $15.58 | +149% | Bullish | |
| $10.76 | $17.26 | $29.74 | +340% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $3.69 | $3.92 | $4.61 | +0.00% |
| June 2026 | $3.44 | $4.03 | $4.81 | +2.74% |
| July 2026 | $3.36 | $3.96 | $4.78 | -1.77% |
| August 2026 | $3.26 | $3.85 | $4.70 | -2.56% |
| September 2026 | $3.26 | $3.88 | $4.76 | +0.66% |
| October 2026 | $3.23 | $3.86 | $4.77 | -0.48% |
| November 2026 | $3.12 | $3.74 | $4.65 | -3.10% |
| December 2026 | $3.11 | $3.74 | $4.67 | +0.00% |
Click any year to see its month-by-month BHST forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
BioHarvest Sciences Inc. Common Stock's 2026 outlook centres on $3.92, within a $3.69 to $4.67 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, BHST could reach as high as $5.49, with a base case around $4.21 and support toward $3.40 — roughly +7% from $3.92. A consolidation phase looks the most probable path here.
Expect BHST to range from $3.49 to $5.93 through 2028. The $4.42 average target implies a +13% move from current prices. That is up +5% on the projected 2027 average. Price action looks broadly range-bound.
The BHST price prediction for 2029 points to an average of $5.11 (low $3.96, high $7.03) — a potential gain of +30% on today's $3.92. Buyers look set to stay in control over this stretch.
In 2030, BHST is projected to trade between $4.40 and $8.09, averaging $5.76 — a potential gain of +47% from today's $3.92. That is up +13% on the projected 2029 average. Momentum favours further upside here.
BioHarvest Sciences Inc. Common Stock's 2031 outlook centres on $5.69, within a $4.28 to $8.14 range. That is -1% versus the projected 2030 average. That marks a +45% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, BHST could reach as high as $8.68, with a base case around $5.98 and support toward $4.44 — roughly +52% from $3.92. Momentum favours further upside here.
Expect BHST to range from $4.49 to $9.03 through 2033. The $6.13 average target implies a +56% move from current prices. That is up +3% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The BHST price prediction for 2034 points to an average of $6.38 (low $4.62, high $9.52) — a potential gain of +63% on today's $3.92. Momentum favours further upside here.
In 2035, BHST is projected to trade between $5.65 and $11.94, averaging $7.90 — a potential gain of +101% from today's $3.92. That is up +24% on the projected 2034 average. Buyers look set to stay in control over this stretch.
BioHarvest Sciences Inc. Common Stock's 2040 outlook centres on $9.77, within a $6.65 to $15.58 range. That is up +24% on the projected 2035 average. That marks a +149% change versus current levels. Momentum favours further upside here.
By 2050, BHST could reach as high as $29.74, with a base case around $17.26 and support toward $10.76 — roughly +340% from $3.92. Buyers look set to stay in control over this stretch.
Investing $1,000 in BHST today (≈ 255.102041 BHST) could be worth
$4,402.73
+$3,402.73 (+340%) by 2050 · US Dollar
Based on the average projected BHST price of $17.26 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BHSTwould be worth at today's price.
$1,000 invested in BHST on May 27, 2025 (≈ 160 BHST) would be worth
$627.2
-$372.8 (-37.3%) today · 0.63× · US Dollar
Based on a BHST entry price of $6.25 vs. today's $3.92.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.72 | $1,053.76 | +5.4% |
| 1 month ago | $4.38 | $894.98 | -10.5% |
| 3 months ago | $4.77 | $821.8 | -17.8% |
| 6 months ago | $6.73 | $582.47 | -41.8% |
| 1 year ago | $6.25 | $627.2 | -37.3% |
| All time (5.0y) ago | $9.14 | $429.12 | -57.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BHST forecast.
Our base-case forecast reaches $7.80 around 2035.
Implied market cap at $7.80: $176.81M
The extended forecast points to a clear bullish trajectory over the coming years. In 2026 the Avg is $3.86 with ROI 0 and sentiment Neutral, followed by a path toward higher values: 2027 Avg $4.11, 2028 Avg $4.25, 2029 Avg $4.95 (ROI 28.3, sentiment Bullish), 2030 Avg $5.59 (ROI 44.7, sentiment Bullish), 2031 Avg $5.47 (41.6, Bullish), 2032 Avg $5.74 (48.7, Bullish), 2033 Avg $5.84 (51.3, Bullish), 2034 Avg $6.03 (56.1, Bullish), 2035 Avg $7.57 (96.2, Bullish).
The bullish trend continues into 2040 with Avg $9.16 (ROI 137.2) and Max $14.81, and culminates in 2050 with Avg $16.26 (ROI 321.1) and Max $28.51. Throughout, the sentiment shifts to Bullish for the later years, supported by increasingly higher price targets and sizeable upside potential, albeit within a context of notable volatility (annualized volatility 40%).
Tap a question to reveal the answer.
Min $4.23; Avg $5.59; Max $7.92; ROI 44.7; Sentiment BULLISH.
The forecast shows neutral to bullish momentum over time, with near-term neutral in 2026 and bullish sentiment from 2029 onward. The 2030 avg is $5.59 (ROI 44.7), 2040 avg $9.16 (ROI 137.2), and 2050 avg $16.26 (ROI 321.1), indicating substantial long-term upside amid volatility (40% annualized).
Yes—the 2050 max price is $28.51, and the 2050 avg is $16.26, placing a $20 level within the forecasted upside by 2050.
Current price is $3.86 and market cap is $87.5M. The stock is ranked 4314 in market capitalization.
Sentiment: BEARISH. RSI(14) is 40. SMA50 is $4.22 and SMA200 is $6.45. Support is $3.69 and resistance is $4.42. The 30-day range is $3.31 to $4.51.
BioHarvest Sciences Inc. Common Stock Community Discussion
0Share your BioHarvest Sciences Inc. Common Stock price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.